Yes, the encouraging idea that sales of the device during trials would defray costs hasn't made any noticeable impact on outgoings
- Forums
- ASX - By Stock
- Ann: Capital Raise
Yes, the encouraging idea that sales of the device during trials...
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.15 |
Change
0.000(0.00%) |
Mkt cap ! $256.8M |
Open | High | Low | Value | Volume |
$12.15 | $12.15 | $12.15 | $12 | 1 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 59 | $11.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.00 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 841 | 11.900 |
1 | 1000 | 11.800 |
1 | 5000 | 11.720 |
1 | 2 | 11.260 |
1 | 8 | 11.220 |
Price($) | Vol. | No. |
---|---|---|
12.150 | 830 | 1 |
12.250 | 175 | 1 |
12.400 | 198 | 1 |
12.800 | 1000 | 1 |
12.850 | 1000 | 1 |
Last trade - 09.59am 07/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |